48. 原発性抗リン脂質抗体症候群 Primary antiphospholipid syndrome Clinical trials / Disease details


臨床試験数 : 5 薬物数 : 6 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 7

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05078710
(ClinicalTrials.gov)
July 1, 202124/9/2021Telitacicept in Primary APS PatientsA Pilot Study of Telitacicept Treatment in Primary APS PatientsAnti Phospholipid SyndromeDrug: TelitaciceptPeking Union Medical College HospitalNULLRecruiting18 Years65 YearsAll20Phase 2China